Biogenesis founder Tony Bosch surrendered to the DEA for peddling performance-enhancing drugs

Biogenesis founder Tony Bosch surrendered to the DEA for peddling performance-enhancing drugs
(Image credit: Sean Gallup/Getty Images)

Disgraced Biogenesis head Tony Bosch, whose now-defunct clinic allegedly distributed performance-enhancing drugs to pro athletes, surrendered early Tuesday morning to the Drug Enforcement Agency. An as-yet unspecified number of others involved in the clinic also turned themselves in as part of the DEA's Operation Strikeout.

The arrests come exactly one year after Major League Baseball announced the suspensions of a dozen players — including Yankees slugger Alex Rodriguez — accused of taking banned substances obtained through the clinic.

Bosch has reportedly reached a deal to plead guilty to conspiracy to distribute steroids, according to ESPN. As ESPN's T.J. Quinn notes, Bosch has not only been tied to pro athletes, but clinic documents indicate he peddled the same substances to well-heeled private citizens and high-school athletes, too.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

Though MLB originally came after Bosch with dubious extralegal tactics in its bid to unveil suspected drug cheats, the league eventually turned him into a star witness in its case against A-Rod.

To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us